Our Products

SOLVING
RADIOISOTOPE SUPPLY

Technetium-99m (Tc-99m) is a diagnostic imaging radioisotope that influences important healthcare decisions daily for more than 40,0001 patients in the U.S., including those with cancer and heart disease.

1DOE/NNSA, “NNSA’s Molybdenum-99 Program: Establishing a Reliable Supply of Mo-99 Produced Without Highly Enriched Uranium”, 2017
PROVIDING RADIOPHARMACIES
WITH RELIABLE Mo-99
SUPPLY REQUIRES

PRODUCTION
OF Mo-99 in
the u.s.


Until now, molybdenum-99 (Mo-99), Tc-99m’s parent isotope, has only been sourced from overseas. NorthStar is unique in that we produce, process and ship Mo-99 from within the U.S., providing for its efficient and reliable distribution.

TECHNOLOGICAL ADVANCES
ENSURE THAT Mo-99
PRODUCTION IS

ECO
friendly

NorthStar has invested in modern, non-uranium production methods, which produce benign and recyclable waste streams that are free of toxic and radioactive waste. It is important to us and to our customers that the Mo-99 we produce in the U.S. does not have significant environmental risks associated with it, unlike those with enriched uranium-based fission Mo-99 production.

TAKE A LOOK
AT WHAT
WE DO

Our process of producing non-uranium Mo-99 begins in Columbia, Missouri.

Watch the rest of the story here.